These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18049729)

  • 1. Carboranyl thymidine analogues for neutron capture therapy.
    Tjarks W; Tiwari R; Byun Y; Narayanasamy S; Barth RF
    Chem Commun (Camb); 2007 Dec; (47):4978-91. PubMed ID: 18049729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
    Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
    J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancer.
    Narayanasamy S; Thirumamagal BT; Johnsamuel J; Byun Y; Al-Madhoun AS; Usova E; Cosquer GY; Yan J; Bandyopadhyaya AK; Tiwari R; Eriksson S; Tjarks W
    Bioorg Med Chem; 2006 Oct; 14(20):6886-99. PubMed ID: 16831554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boronated thymidine analogues for boron neutron capture therapy.
    Thirumamagal BT; Johnsamuel J; Cosquer GY; Byun Y; Yan J; Narayanasamy S; Tjarks W; Barth RF; Al-Madhoun AS; Eriksson S
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):861-6. PubMed ID: 16901817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of ethyleneoxide modified 3-carboranyl thymidine analogues and evaluation of their biochemical, physicochemical, and structural properties.
    Johnsamuel J; Lakhi N; Al-Madhoun AS; Byun Y; Yan J; Eriksson S; Tjarks W
    Bioorg Med Chem; 2004 Sep; 12(18):4769-81. PubMed ID: 15336255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis and biochemical evaluation of thymidine analogues substituted with nido carborane at the N-3 position.
    Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
    Appl Radiat Isot; 2004 Nov; 61(5):1125-30. PubMed ID: 15308203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 3'-carboranyl thymidine analogues.
    Yan J; Naeslund C; Al-Madhoun AS; Wang J; Ji W; Cosquer GY; Johnsamuel J; Sjöberg S; Eriksson S; Tjarks W
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2209-12. PubMed ID: 12127539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.
    Barth RF; Yang W; Wu G; Swindall M; Byun Y; Narayanasamy S; Tjarks W; Tordoff K; Moeschberger ML; Eriksson S; Binns PJ; Riley KJ
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17493-7. PubMed ID: 18981415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors.
    Byun Y; Thirumamagal BT; Yang W; Eriksson S; Barth RF; Tjarks W
    J Med Chem; 2006 Sep; 49(18):5513-23. PubMed ID: 16942024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N3-substituted thymidine bioconjugates for cancer therapy and imaging.
    Khalil A; Ishita K; Ali T; Tjarks W
    Future Med Chem; 2013 Apr; 5(6):677-92. PubMed ID: 23617430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
    Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
    Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1.
    Agarwal HK; McElroy CA; Sjuvarsson E; Eriksson S; Darby MV; Tjarks W
    Eur J Med Chem; 2013 Feb; 60():456-68. PubMed ID: 23318906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to magnetic neutron capture therapy.
    Kuznetsov AA; Podoynitsyn SN; Filippov VI; Komissarova LKh; Kuznetsov OA
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):930-3. PubMed ID: 16199321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer.
    Tjarks W; Wang J; Chandra S; Ji W; Zhuo J; Lunato AJ; Boyer C; Li Q; Usova EV; Eriksson S; Morrison GH; Cosquer GY
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):695-8. PubMed ID: 11563094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer.
    Agarwal HK; Khalil A; Ishita K; Yang W; Nakkula RJ; Wu LC; Ali T; Tiwari R; Byun Y; Barth RF; Tjarks W
    Eur J Med Chem; 2015 Jul; 100():197-209. PubMed ID: 26087030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapy.
    Byun Y; Narayanasamy S; Johnsamuel J; Bandyopadhyaya AK; Tiwari R; Al-Madhoun AS; Barth RF; Eriksson S; Tjarks W
    Anticancer Agents Med Chem; 2006 Mar; 6(2):127-44. PubMed ID: 16529536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of in vitro cytotoxicity of carboranyl amino acids, their chemical precursors and nido carboranyl amino acids for boron neutron capture therapy.
    Yong JH; Barth RF; Rotaru JH; Wyzlic IM; Soloway AH
    Anticancer Res; 1995; 15(5B):2039-43. PubMed ID: 8572599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy.
    Al-Madhoun AS; Johnsamuel J; Barth RF; Tjarks W; Eriksson S
    Cancer Res; 2004 Sep; 64(17):6280-6. PubMed ID: 15342416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapy.
    Sjuvarsson E; Damaraju VL; Mowles D; Sawyer MB; Tiwari R; Agarwal HK; Khalil A; Hasabelnaby S; Goudah A; Nakkula RJ; Barth RF; Cass CE; Eriksson S; Tjarks W
    J Pharmacol Exp Ther; 2013 Nov; 347(2):388-97. PubMed ID: 24006340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new boron-rich building blocks for boron neutron capture therapy or energy-filtering transmission electron microscopy.
    Raddatz S; Marcello M; Kliem HC; Tröster H; Trendelenburg MF; Oeser T; Granzow C; Wiessler M
    Chembiochem; 2004 Apr; 5(4):474-82. PubMed ID: 15185371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.